Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort - PubMed (original) (raw)
. 1992 Apr;102(4 Pt 1):1212-9.
Affiliations
- PMID: 1551528
Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort
B J Reid et al. Gastroenterology. 1992 Apr.
Abstract
To determine whether or not flow-cytometric evidence of aneuploidy and increased G2/tetraploid fractions predispose to neoplastic progression in Barrett's esophagus, 62 patients with Barrett's esophagus were evaluated prospectively for a mean interval of 34 months. Nine of 13 patients who showed aneuploid or increased G2/tetraploid populations in their initial flow-cytometric analysis developed high-grade dysplasia or adenocarcinoma during follow-up; none of the 49 patients without these abnormalities progressed to high-grade dysplasia or cancer (P less than 0.0001). Neoplastic progression was characterized by progressive flow-cytometric and histological abnormalities. Patients who progressed to high-grade dysplasia and carcinoma frequently developed multiple aneuploid populations of cells that were detectable flow-cytometrically. Similarly, patients appeared to progress through a phenotypic sequence that could be recognized histologically by the successive appearance of Barrett's metaplasia negative for dysplasia, abnormalities in the indefinite/low-grade dysplasia range, high-grade dysplasia, and eventually adenocarcinoma. These and prior results suggest that neoplastic progression in Barrett's esophagus occurs in a subset of patients who have an acquired genomic instability that generates abnormal clones of cells, some of which have aneuploid or increased G2/tetraploid DNA contents. With continued genomic instability, multiple aneuploid subclones may evolve, one of which may ultimately acquire the ability to invade and become an early carcinoma. The combination of histology and flow cytometry can be used to identify a subset of patients with Barrett's esophagus who merit more frequent endoscopic surveillance for the early detection of high-grade dysplasia or carcinoma.
Comment in
- Barrett's esophagus and adenocarcinoma: from the family to the gene.
Cameron AJ. Cameron AJ. Gastroenterology. 1992 Apr;102(4 Pt 1):1421-4. doi: 10.1016/0016-5085(92)90789-2. Gastroenterology. 1992. PMID: 1551552 No abstract available.
Similar articles
- Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.
Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS. Reid BJ, et al. Gastroenterology. 1987 Jul;93(1):1-11. Gastroenterology. 1987. PMID: 3582897 - Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.
Levine DS, Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS. Levine DS, et al. Gastroenterology. 1989 Feb;96(2 Pt 1):355-67. doi: 10.1016/s0016-5085(89)91559-x. Gastroenterology. 1989. PMID: 2910757 - Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.
Ramel S, Reid BJ, Sanchez CA, Blount PL, Levine DS, Neshat K, Haggitt RC, Dean PJ, Thor K, Rabinovitch PS. Ramel S, et al. Gastroenterology. 1992 Apr;102(4 Pt 1):1220-8. Gastroenterology. 1992. PMID: 1551529 - Barrett's esophagus, dysplasia, and adenocarcinoma.
Haggitt RC. Haggitt RC. Hum Pathol. 1994 Oct;25(10):982-93. doi: 10.1016/0046-8177(94)90057-4. Hum Pathol. 1994. PMID: 7927321 Review. - The diagnosis and management of Barrett's esophagus.
DeMeester SR, DeMeester TR. DeMeester SR, et al. Adv Surg. 1999;33:29-68. Adv Surg. 1999. PMID: 10572561 Review.
Cited by
- Role of surveillance in intestinal metaplasia of the esophagus and gastroesophageal junction.
Tytgat GN, Van Sandick JW, Lanschot JJ, Obertop H. Tytgat GN, et al. World J Surg. 2003 Sep;27(9):1021-5. doi: 10.1007/s00268-003-7194-2. Epub 2003 Aug 18. World J Surg. 2003. PMID: 12917755 Review. - Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.
Findlay JM, Middleton MR, Tomlinson I. Findlay JM, et al. Dig Dis Sci. 2016 Jan;61(1):25-38. doi: 10.1007/s10620-015-3884-5. Epub 2015 Oct 7. Dig Dis Sci. 2016. PMID: 26445852 Free PMC article. - Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome--an update.
Tseng EE, Wu TT, Yeo CJ, Heitmiller RF. Tseng EE, et al. J Gastrointest Surg. 2003 Feb;7(2):164-70; discussion 170-1. doi: 10.1016/s1091-255x(02)00153-1. J Gastrointest Surg. 2003. PMID: 12600440 - Barrett's oesophagus: Current controversies.
Amadi C, Gatenby P. Amadi C, et al. World J Gastroenterol. 2017 Jul 28;23(28):5051-5067. doi: 10.3748/wjg.v23.i28.5051. World J Gastroenterol. 2017. PMID: 28811703 Free PMC article. Review. - American Gastroenterological Association technical review on the management of Barrett's esophagus.
Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. Spechler SJ, et al. Gastroenterology. 2011 Mar;140(3):e18-52; quiz e13. doi: 10.1053/j.gastro.2011.01.031. Gastroenterology. 2011. PMID: 21376939 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical